Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Fiet

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Hypertension (Dallas, Tex. : 1979)|February 26, 2004
Impaired 11-beta hydroxysteroid dehydrogenase type 2 activity in sweat gland ducts in human essential hypertensionBrigitte Bocchi, Sabine Kenouch, Maxime Lamarre-Cliche, et al.
The Prostate|October 30, 2018
Sex steroids in serum and prostatic tissue of human cancerous prostate (STERKPROSER trial)Matthias E Meunier, Yann Neuzillet, Jean-Pierre Raynaud, et al.
The Journal of Steroid Biochemistry and Molecular Biology|March 14, 2008
Estrone sulfate (E1S), a prognosis marker for tumor aggressiveness in prostate cancer (PCa)Frank Giton, Alexandre de la Taille, Yves Allory, et al.
Human Reproduction (Oxford, England)|November 25, 2022
Combining metabolomics and machine learning models as a tool to distinguish non-classic 21-hydroxylase deficiency from polycystic ovary syndrome without adrenocorticotropic hormone testingGuillaume Bachelot, Anne Bachelot, Marion Bonnier, et al.
European Journal of Endocrinology|August 13, 2024
Plasma 21-deoxycortisone: a sensitive additive tool in 21-hydroxylase deficiency in newbornsJean Fiet, Guillaume Bachelot, Coumba Sow, et al.
European Journal of Endocrinology|October 9, 2025
Advances in congenital adrenal hyperplasia newborn screening: 11-ketotestosterone and 21-deoxycortisone as additional discriminatory biomarkersCoumba Sow, Thao Nguyen-Khoa, Caroline Moreau, et al.
European Urology Oncology|August 29, 2024
Final Results of the ANDROCAN Study: Histopathological Characteristics and Biochemical Recurrence at 5 Years of Localized Prostate Cancer According to Preoperative Gonadal StatusYann Neuzillet, Jean-Pierre Raynaud, Jean-François Dreyfus, et al.
Hormones & Cancer|October 8, 2018
Aggressiveness of Localized Prostate Cancer: the Key Value of Testosterone Deficiency Evaluated by Both Total and Bioavailable Testosterone: AndroCan Study ResultsYann Neuzillet, Jean-Pierre Raynaud, Jean-François Dreyfus, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Hypertension (Dallas, Tex. : 1979)|February 26, 2004
Impaired 11-beta hydroxysteroid dehydrogenase type 2 activity in sweat gland ducts in human essential hypertensionBrigitte Bocchi, Sabine Kenouch, Maxime Lamarre-Cliche, et al.
The Prostate|October 30, 2018
Sex steroids in serum and prostatic tissue of human cancerous prostate (STERKPROSER trial)Matthias E Meunier, Yann Neuzillet, Jean-Pierre Raynaud, et al.
The Journal of Steroid Biochemistry and Molecular Biology|March 14, 2008
Estrone sulfate (E1S), a prognosis marker for tumor aggressiveness in prostate cancer (PCa)Frank Giton, Alexandre de la Taille, Yves Allory, et al.
Human Reproduction (Oxford, England)|November 25, 2022
Combining metabolomics and machine learning models as a tool to distinguish non-classic 21-hydroxylase deficiency from polycystic ovary syndrome without adrenocorticotropic hormone testingGuillaume Bachelot, Anne Bachelot, Marion Bonnier, et al.
European Journal of Endocrinology|August 13, 2024
Plasma 21-deoxycortisone: a sensitive additive tool in 21-hydroxylase deficiency in newbornsJean Fiet, Guillaume Bachelot, Coumba Sow, et al.
European Journal of Endocrinology|October 9, 2025
Advances in congenital adrenal hyperplasia newborn screening: 11-ketotestosterone and 21-deoxycortisone as additional discriminatory biomarkersCoumba Sow, Thao Nguyen-Khoa, Caroline Moreau, et al.
European Urology Oncology|August 29, 2024
Final Results of the ANDROCAN Study: Histopathological Characteristics and Biochemical Recurrence at 5 Years of Localized Prostate Cancer According to Preoperative Gonadal StatusYann Neuzillet, Jean-Pierre Raynaud, Jean-François Dreyfus, et al.
Hormones & Cancer|October 8, 2018
Aggressiveness of Localized Prostate Cancer: the Key Value of Testosterone Deficiency Evaluated by Both Total and Bioavailable Testosterone: AndroCan Study ResultsYann Neuzillet, Jean-Pierre Raynaud, Jean-François Dreyfus, et al.
Pageof 4